Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer

Saved in:
Bibliographic Details
Published in:Translational Respiratory Medicine
Format: Online Article RSS Article
Published: 2014
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864030186687692806
collection WordPress RSS
FRELIP Feed Integration
container_title Translational Respiratory Medicine
description
discipline_display Technology & Engineering
discipline_facet Technology & Engineering
format Online Article
RSS Article
genre Journal Article
id rss_article:13876
institution FRELIP
journal_source_facet Translational Respiratory Medicine
publishDate 2014
publishDateSort 2014
record_format rss_article
spellingShingle Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
Bioengineering
Bioengineering
Technology & Engineering
sub_discipline_display Bioengineering
sub_discipline_facet Bioengineering
subject_display Bioengineering
Bioengineering
Technology & Engineering
Bioengineering
Bioengineering
Technology & Engineering
subject_facet Bioengineering
Bioengineering
Technology & Engineering
title Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
title_auth Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
title_full Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
title_fullStr Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
title_full_unstemmed Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
title_short Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
title_sort second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
topic Bioengineering
Bioengineering
Technology & Engineering
url https://link.springer.com/article/10.1186/2213-0802-2-2